<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36863699</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>American journal of medical genetics. Part A</Title><ISOAbbreviation>Am J Med Genet A</ISOAbbreviation></Journal><ArticleTitle>Neonatal lupus is a novel cause of positive newborn screening for X-linked adrenoleukodystrophy.</ArticleTitle><Pagination><StartPage>1412</StartPage><EndPage>1417</EndPage><MedlinePgn>1412-1417</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.63144</ELocationID><Abstract><AbstractText>We report three unrelated individuals, each exposed to maternal autoantibodies during gestation and found to have elevated very long-chain fatty acids (VLCFAs) in the newborn period after screening positive by California newborn screening (NBS) for X-linked adrenoleukodystrophy (ALD). Two probands presented with clinical and laboratory features of neonatal lupus erythematosus (NLE); the third had features suggestive of NLE and a known maternal history of Sjogren's syndrome and rheumatoid arthritis. In all three individuals, subsequent biochemical and molecular evaluation for primary and secondary peroxisomal disorders was nondiagnostic with normalization of VLCFAs by 15&#x2009;months of age. These cases add to the expanding differential diagnosis to consider in newborns who screen positive for ALD via elevated C26:0-lysophosphatidylcholine. Though the pathophysiology of how transplacental maternal anti-Ro antibodies damage fetal tissue is not well-understood, we postulate that the VLCFA elevations reflect a systemic inflammatory response and secondary peroxisomal dysfunction that improves once maternal autoantibodies wane after birth. Additional evaluation of this phenomenon is warranted to better understand the intricate biochemical, clinical, and possible therapeutic overlap between autoimmunity, inflammation, peroxisomal dysfunction, and human disease.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niehaus</LastName><ForeName>Annie D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-9425-3073</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendelsohn</LastName><ForeName>Bryce A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Kaiser Permanente Northern California, Oakland, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Bree</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Kaiser Permanente Northern California, Oakland, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chung U</ForeName><Initials>CU</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manning</LastName><ForeName>Melanie A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cusmano-Ozog</LastName><ForeName>Kristina P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tise</LastName><ForeName>Christina G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-6227-7895</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet A</MedlineTA><NlmUniqueID>101235741</NlmUniqueID><ISSNLinking>1552-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C536397">Neonatal Systemic lupus erythematosus</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000326" MajorTopicYN="Y">Adrenoleukodystrophy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015997" MajorTopicYN="N">Neonatal Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">X-linked adrenoleukodystrophy (ALD)</Keyword><Keyword MajorTopicYN="N">maternal autoimmune conditions</Keyword><Keyword MajorTopicYN="N">neonatal lupus erythematosus</Keyword><Keyword MajorTopicYN="N">newborn screening</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>19</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36863699</ArticleId><ArticleId IdType="doi">10.1002/ajmg.a.63144</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Buyon, J. P., &amp; Friedman, D. M. (2011). Neonatal lupus. Systemic Lupus Erythematosus, 541-571.</Citation></Reference><Reference><Citation>Clancy, R. M., Kapur, R. P., Molad, Y., Askanase, A. D., &amp; Buyon, J. P. (2004). Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis &amp; Rheumatism: Official Journal of the American College of Rheumatology, 50(1), 173-182.</Citation></Reference><Reference><Citation>Clancy, R. M., Neufing, P. J., Zheng, P., O'Mahony, M., Nimmerjahn, F., Gordon, T. P., &amp; Buyon, J. P. (2006). Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and-SSB/La antibodies in the pathogenesis of congenital heart block. The Journal of Clinical Investigation, 116(9), 2413-2422.</Citation></Reference><Reference><Citation>Di Cara, F., Andreoletti, P., Trompier, D., Vejux, A., B&#xfc;low, M. H., Sellin, J., Lizard, G., Cherkaoui-Malki, M., &amp; Savary, S. (2019). Peroxisomes in immune response and inflammation. International Journal of Molecular Sciences, 20(16), 3877.</Citation></Reference><Reference><Citation>Fairweather, D., &amp; Rose, N. R. (2004). Women and autoimmune diseases. Emerging Infectious Diseases, 10(11), 2005-2011.</Citation></Reference><Reference><Citation>Friedman, D. M., Duncanson, L. J., Glickstein, J., &amp; Buyon, J. P. (2003). A review of congenital heart block. Images in Paediatric Cardiology, 5(3), 36-48.</Citation></Reference><Reference><Citation>Mallack, E. J., Turk, B., Yan, H., &amp; Eichler, F. S. (2019). The landscape of hematopoietic stem cell transplant and gene therapy for X-linked adrenoleukodystrophy. Current Treatment Options in Neurology, 21(12), 1-11.</Citation></Reference><Reference><Citation>Matteson, J., Sciortino, S., Feuchtbaum, L., Bishop, T., Olney, R. S., &amp; Tang, H. (2021). Adrenoleukodystrophy newborn screening in California since 2016: Programmatic outcomes and follow-up. International Journal of Neonatal Screening, 7(2), 22.</Citation></Reference><Reference><Citation>Raymond, G. V., Aubourg, P., Paker, A., Escolar, M., Fischer, A., Blanche, S., Baruchel, A., Dalle, J. H., Michel, G., Prasad, V., Miller, W., Paadre, S., Balser, J., Kurtzberg, J., Nascene, D. R., Orchard, P. J., &amp; Lund, T. (2019). Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 25(3), 538-548.</Citation></Reference><Reference><Citation>Recommended Uniform Screening Panel. (2017). Official web site of the U.S Health Resources &amp; Services Administration. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp/index.html</Citation></Reference><Reference><Citation>Steinberg, L. (2021). Congenital heart block. Cardiac Electrophysiology Clinics, 13(4), 691-702.</Citation></Reference><Reference><Citation>Tise, C. G., Morales, J. A., Lee, A. S., Velez-Bartolomei, F., Floyd, B. J., Levy, R. J., Cusmano-Ozog, K. P., Feigenbaum, A. S., Ruzhnikov, M. R. Z., Lee, C. U., &amp; Enns, G. M. (2021). Aicardi-Gouti&#xe8;res syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy. American Journal of Medical Genetics Part A, 185(6), 1848-1853.</Citation></Reference><Reference><Citation>Zuppa, A. A., Riccardi, R., Frezza, S., Gallini, F., Luciano, R. M. P., Alighieri, G., Romagnoli, C., &amp; De Carolis, S. (2017). Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Autoimmunity Reviews, 16(4), 427-432.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>